2010
DOI: 10.1093/gerona/glq180
|View full text |Cite
|
Sign up to set email alerts
|

Is Telomere Length a Biomarker of Aging? A Review

Abstract: Telomeres, the DNA-protein structures located at the ends of chromosomes, have been proposed to act as a biomarker of aging. In this review, the human evidence that telomere length is a biomarker of aging is evaluated. Although telomere length is implicated in cellular aging, the evidence suggesting telomere length is a biomarker of aging in humans is equivocal. More studies examining the relationships between telomere length and mortality and with measures that decline with "normal" aging in community samples… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
291
1
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 375 publications
(303 citation statements)
references
References 101 publications
6
291
1
1
Order By: Relevance
“…Third, we tested 2 indicators of accelerated aging. Although some commentators have questioned whether TL is an appropriate biomarker of aging, 36 we confirmed a previous report that shorter TL is associated with older perceived age in the expected direction. 8 We used a perinatal complication index that was previously shown to predict cognitive problems in the Dunedin Study at ages 3, 5, 7, 11, and 13 years.…”
Section: Discussionsupporting
confidence: 89%
“…Third, we tested 2 indicators of accelerated aging. Although some commentators have questioned whether TL is an appropriate biomarker of aging, 36 we confirmed a previous report that shorter TL is associated with older perceived age in the expected direction. 8 We used a perinatal complication index that was previously shown to predict cognitive problems in the Dunedin Study at ages 3, 5, 7, 11, and 13 years.…”
Section: Discussionsupporting
confidence: 89%
“…Thus, our findings may not apply to other cell types or tissues in the body or to acutely or severely ill inpatients with the illness. Another limitation of this, and other published studies of LTL in schizophrenia, is the use of a crosssectional design, which makes assessments of telomere trajectory or rate of telomere shortening in individual subjects impossible (Mather et al, 2011). Unless all trajectories of LTL with age parallel each other, the trajectory of LTL with age in cross-sectional studies does not well indicate the individual trajectories for subjects in the population (Kraemer et al, 2000;Louis et al, 1986;Vollmer, 1993).…”
Section: Discussionmentioning
confidence: 96%
“…Due to relatively high inter-individual variability in LTL at any time point, clearer interpretations are possible only from examining intra-individual, rather than between-individual or betweengroup, patterns longitudinally (Mather et al, 2011). Such studies should always include an HC group, separate analyses of men and women, adequate sample sizes within each group, consideration of possible differences in the aging process in each group (gender and diagnosis), and careful consideration of other covariates either interacting with, or collinear with gender, age, or diagnosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Telomere maintenance has relevance for long-term health. Shortened telomere length and/or reduced telomerase activity have been consistently associated with health risk and diseases (12)(13)(14)(15). Declines in the telomere/telomerase maintenance system may play a causal role in aging, serve as a biomarker of aging, or both.…”
Section: Developmental Programming | Fetal Originmentioning
confidence: 99%